Literature DB >> 11054365

Factitious hyperkalemia.

M R Wiederkehr1, O W Moe.   

Abstract

Pseudohyperkalemia, or factitious hyperkalemia, constitutes an artificially high plasma potassium level (P(K)) from a variety of possible causes. Occasionally, the cause cannot be elucidated. Three patients who showed unusually large differences between free-flowing and tourniquet (stasis) potassium levels prompted us to investigate the influence of tourniquets in routine phlebotomy in eight healthy volunteers. P(K) showed a consistent but rather small average increase of 0.2 mEq/L (P < 0.001) during tourniquet use; however, the range was 10-fold, from 0.05 to 0.5 mEq/L in our subjects. We suggest there may be large variability leading to an excessive increase in P(K) in some individuals. In the three patients presented, average excessive increases in P(K) of 1.6, 1.3, and 1.7 mEq/L were seen. Although diagnosing and treating true hyperkalemia remains paramount, recognizing factitious hyperkalemia is important to preclude unnecessary investigations and potentially hazardous intervention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054365     DOI: 10.1053/ajkd.2000.19084

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  Pseudohyperkalemia in patients with chronic lymphocytic leukemia.

Authors:  Stephen I Rifkin
Journal:  Int J Nephrol       Date:  2011-03-23

2.  A case of severe pseudohyperkalaemia due to muscle contraction.

Authors:  Jan Van Elslande; Toon Dominicus; Jaan Toelen; Glynis Frans; Pieter Vermeersch
Journal:  Biochem Med (Zagreb)       Date:  2020-06-15       Impact factor: 2.313

3.  Pseudohyperkalemia in a Patient With Chronic Lymphocytic Leukemia.

Authors:  Rahul Gujarathi; Venu Chippa; Narsimha Candula; Meet Kadakia
Journal:  Cureus       Date:  2022-03-26

Review 4.  Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference.

Authors:  Gregor Lindner; Emmanuel A Burdmann; Catherine M Clase; Brenda R Hemmelgarn; Charles A Herzog; Jolanta Małyszko; Masahiko Nagahama; Roberto Pecoits-Filho; Zubaid Rafique; Patrick Rossignol; Adam J Singer
Journal:  Eur J Emerg Med       Date:  2020-10       Impact factor: 4.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.